Literature DB >> 7523000

Inhibin as a marker for hydatidiform mole: a comparative study with the determinations of intact human chorionic gonadotrophin and its free beta-subunit.

Y Badonnel1, F Barbé, H Legagneur, E Poncelet, M Schweitzer.   

Abstract

OBJECTIVE: The purpose of the study was to evaluate plasma inhibin as a marker of hydatidiform mole and to compare the results with intact human chorionic gonadotrophin (hCG) and its free beta-subunit.
DESIGN: Serial determinations of the plasma concentrations of inhibin, intact human chorionic gonadotrophin and its free beta-subunit in cases of hydatidiform mole over an average period of 140 days. PATIENTS: Five cases of hydatidiform mole, including patients with spontaneous remission after evacuation or persistent trophoblastic disease. MEASUREMENTS: Immunoreactive inhibin, hCG and free hCG beta-subunit were measured using standard enzyme immunoassays.
RESULTS: Inhibin and free hCG beta-subunit levels were greater than in normal pregnant women at the same gestational age. Only intact hCG could detect the persistence of trophoblastic tissue.
CONCLUSIONS: Our data suggest that inhibin, intact human chorionic gonadotrophin and free beta-subunit might be useful as diagnostic markers of molar pregnancies. However, the original method of intact hCG determination is still superior for follow-up.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523000     DOI: 10.1111/j.1365-2265.1994.tb02524.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  1 in total

1.  Serum levels of dimeric activin A are not a marker of placental tumors in the course of chemotherapy.

Authors:  P Florio; S Luisi; E Casarosa; A R Genazzani; P Pautier; C Lhommé; J M Bidart; P G Driul; F Petraglia
Journal:  J Endocrinol Invest       Date:  1998-03       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.